Applied DNA Sciences Inc (NASDAQ:APDN) shares fell 2.63% to $1.85 on Friday and were flat in after-hours trading. Share prices have been trading in a 52-week range of $1.73 to $3.74. The company has a market cap of $47.47 million at 26.35 million shares outstanding.
Following its string of appointments last year, Applied DNA Sciences kicked off 2017 by announcing that Dr. Mehmood Khan, PepsiCo’s Vice Chairman and Chief Scientific Officer, Global Research and Development, has joined the Company’s Strategic Advisory Board. In PepsiCo, Dr. Khan is in charge of research and development efforts, creating breakthrough innovations in food and beverage product development, delivery, packaging and production technology.
Apart from that, he also oversees PepsiCo’s global Performance with Purpose agenda, focused on improving health and well-being through the products it sells. He wasrecently appointed Vice Chair of the US Council for Competitiveness and joined the Board of the Foundation for Food and Agriculture Research at the USDA.
“We are thrilled to have Dr. Khan’s keen scientific insight and robust commercial experience to help us grow our business in new and growing markets. His decades of involvement in the global food, beverage and pharmaceutical industries, as well as his depth of scientific innovation experience, are a perfect complement to Applied DNA as we expand our core vertical markets. With Dr. Khan’s appointment to the FFAR, and its engagement with both the National Science Foundation and the U.S. Department of Agriculture, Applied DNA hopes to optimize their benefits to American agronomy and to the world in general. We are honored to have him join our SAB,” remarked Applied DNA Sciences CEO Dr. James Hayward.
“Authentication and traceability across complex global supply chains is a critically important priority worldwide. Applied DNA is doing exciting work designed to create innovative solutions that make supply chains more secure. I am honored to join their Strategic Advisory Board and look forward to contributing to their ongoing efforts to protect the integrity of supply chains across industries,” stated Dr. Khan.
In 2016, Applied DNA Sciences appointed Bob Miglani as Chief of Business Development to focus on building the company’s business within the FDA-regulated markets and Robert B. Catell to its Board of Directors to assist in the company’s expansion into the protection of critical infrastructure in power grids and railways.
Applied DNA Sciences Inc is a company that is engaged in creating security solutions addressing the challenges of modern commerce, as well as the large-scale production of specific deoxyribonucleic acid sequences using the polymerase chain reaction.
Its principal technology platform includes SigNature DNA, SigNature T DNA, fiberTyping, DNAnet, digitalDNA, SigNify and Beacon. Its SigNify IF portable DNA reader provides definitive real-time authentication of SigNature DNA in the field-DNA becomes a solution for supply chain integrity.
SigNature DNA is the company’s platform ingredient, at the core of all its security solutions. It provides forensic power and protection for a range of applications. SigNature T DNA is a tagging and authentication system specifically designed for textiles and apparel. DNAnet is a DNA marker that can be used to definitively link evidence and offenders to specific crime scenes and help return stolen or lost property to its rightful owner.